Ditchcarbon
  • Contact
  1. Organizations
  2. Chiesi Farmaceutici
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
IT
updated 12 days ago

Chiesi Farmaceutici

Company website

Chiesi Farmaceutici, a prominent player in the global pharmaceutical industry, is headquartered in Parma, Italy. Founded in 1935, the company has established a strong presence in various operational regions, including Europe, North America, and Asia. Specialising in innovative treatments for respiratory diseases, neonatology, and rare diseases, Chiesi is renowned for its commitment to research and development, which has led to several key milestones in the biopharmaceutical sector. The company’s core products, including advanced inhalation therapies and specialty medicines, are distinguished by their focus on patient-centric solutions. Chiesi Farmaceutici has garnered recognition for its sustainable practices and dedication to improving health outcomes, positioning itself as a leader in the pharmaceutical market. With a rich history and a forward-thinking approach, Chiesi continues to make significant contributions to healthcare worldwide.

DitchCarbon Score

How does Chiesi Farmaceutici's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

82

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Chiesi Farmaceutici's score of 82 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

89%

Let us know if this data was useful to you

Chiesi Farmaceutici's reported carbon emissions

In 2024, Chiesi Farmaceutici reported total greenhouse gas emissions of approximately 1,022,663,000 kg CO2e. This includes 24,653,000 kg CO2e from Scope 1 emissions, 49,600 kg CO2e from Scope 2 (market-based), and a significant 997,514,000 kg CO2e from Scope 3 emissions. In 2023, the total emissions were about 980,116,000 kg CO2e, with Scope 1 at 29,906,000 kg CO2e, Scope 2 (market-based) at 591,000 kg CO2e, and Scope 3 at 949,619,000 kg CO2e. Chiesi has set ambitious climate commitments, aiming to achieve a 50% reduction in both Scope 1 and Scope 2 emissions by 2030, using 2019 as the baseline year. Additionally, the company targets a 90% reduction in absolute Scope 3 emissions by 2035. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect a commitment to net-zero emissions across all scopes by 2035. The company has made notable progress, achieving a 12% reduction in Scope 1 emissions and a 96% reduction in Scope 2 market-based emissions compared to the 2019 baseline. Chiesi's sustainability strategy includes a focus on renewable energy, with 99% of electricity consumption sourced from renewable sources at most sites. Overall, Chiesi Farmaceutici's climate strategy demonstrates a robust commitment to reducing its carbon footprint and contributing to global climate goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20172018201920202021202220232024
Scope 1
21,729,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
17,985,000
00,000,000
00,000,000
0,000,000
0,000,000
000,000
000,000
000,000
Scope 3
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Chiesi Farmaceutici's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Chiesi Farmaceutici is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Chiesi Farmaceutici is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Genzyme Corporation, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Aptalis Holdings Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Curia

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy